Key points:
1. TRIP offers a broad spectrum of information about regenerative medicine and cell therapy, comprising news, studies, clinical trials, regulations, and instructions.
2. TRIP contains 14,224 non-redundant entries and presents up-to-date data categorized according to the International Classification of Disease (ICD) 11/ 10 on regulatory obligations and clinical trials.
3. TRIP is open to the public without any login or registration.
4. TRIP provides a three-tier stem cell submission system for users which an administrator will examine and further review by a professional panel
